Source: Lancet infectious diseases. Unidade: FM
Subjects: IMUNIZAÇÃO, VACINAS VIRAIS, DENGUE, POLÍTICA DE SAÚDE, ESTRATÉGIAS MUNDIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDER-SMITH, Annelies e NOVAES, Hillegonde Maria. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. Lancet infectious diseases, v. 19, n. 1, p. E31-E38, 2019Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(18)30494-8. Acesso em: 17 maio 2024.APA
Wilder-smith, A., & Novaes, H. M. (2019). Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine. Lancet infectious diseases, 19( 1), E31-E38. doi:10.1016/S1473-3099(18)30494-8NLM
Wilder-smith A, Novaes HM. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine [Internet]. Lancet infectious diseases. 2019 ; 19( 1): E31-E38.[citado 2024 maio 17 ] Available from: https://doi.org/10.1016/S1473-3099(18)30494-8Vancouver
Wilder-smith A, Novaes HM. Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine [Internet]. Lancet infectious diseases. 2019 ; 19( 1): E31-E38.[citado 2024 maio 17 ] Available from: https://doi.org/10.1016/S1473-3099(18)30494-8
